| __timestamp | Alpine Immune Sciences, Inc. | BioCryst Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2287709 | 7461000 |
| Thursday, January 1, 2015 | 6844000 | 13047000 |
| Friday, January 1, 2016 | 8586000 | 11253000 |
| Sunday, January 1, 2017 | 6079000 | 13933000 |
| Monday, January 1, 2018 | 8362000 | 29514000 |
| Tuesday, January 1, 2019 | 9467000 | 37121000 |
| Wednesday, January 1, 2020 | 10899000 | 67929000 |
| Friday, January 1, 2021 | 14560000 | 118818000 |
| Saturday, January 1, 2022 | 17968000 | 159371000 |
| Sunday, January 1, 2023 | 22222000 | 213894000 |
Unlocking the unknown
In the ever-evolving biotech industry, effective cost management is crucial for sustaining growth and innovation. Over the past decade, Alpine Immune Sciences, Inc. and BioCryst Pharmaceuticals, Inc. have demonstrated distinct trajectories in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Alpine Immune Sciences saw a nearly tenfold increase in SG&A expenses, reflecting strategic investments in operational expansion. Meanwhile, BioCryst Pharmaceuticals experienced a staggering 28-fold rise, indicating aggressive scaling and market penetration efforts. Notably, 2023 marked a peak for both companies, with BioCryst's expenses reaching approximately 10 times that of Alpine's. This divergence underscores the varied approaches within the biotech sector, where financial strategies are as diverse as the innovations they fuel. As these companies continue to navigate the complexities of the market, their SG&A trends offer valuable insights into their operational priorities and future directions.
Breaking Down SG&A Expenses: Gilead Sciences, Inc. vs BioCryst Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for BeiGene, Ltd. and Alpine Immune Sciences, Inc.
SG&A Efficiency Analysis: Comparing Neurocrine Biosciences, Inc. and BioCryst Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Insmed Incorporated or BioCryst Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Bio-Techne Corporation vs Alpine Immune Sciences, Inc.
Operational Costs Compared: SG&A Analysis of Blueprint Medicines Corporation and Alpine Immune Sciences, Inc.
Cost Management Insights: SG&A Expenses for Madrigal Pharmaceuticals, Inc. and Alpine Immune Sciences, Inc.
Alpine Immune Sciences, Inc. vs ADMA Biologics, Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Alpine Immune Sciences, Inc. and ACADIA Pharmaceuticals Inc.
SG&A Efficiency Analysis: Comparing ADMA Biologics, Inc. and BioCryst Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Bausch Health Companies Inc. and BioCryst Pharmaceuticals, Inc.
Mesoblast Limited and BioCryst Pharmaceuticals, Inc.: SG&A Spending Patterns Compared